Literature DB >> 8712878

Course and characteristics of anaemia in patients with rheumatoid arthritis of recent onset.

H R Peeters1, M Jongen-Lavrencic, A N Raja, H S Ramdin, G Vreugdenhil, F C Breedveld, A J Swaak.   

Abstract

OBJECTIVE: To describe the incidence, cause, and course of anaemia in rheumatoid arthritis (RA).
METHODS: Medical records of 225 patients who received a diagnosis of RA between 1990 and 1992 were reviewed longitudinally for mention of anaemia. Anaemia was classified as anaemia of chronic disease if ferritin concentrations reflected adequate body iron stores. Among iron depleted anaemic patients, iron deficiency anaemia was identified using the response to iron supplementation.
RESULTS: Anaemia developed in 64% of the patients, mostly within 18 months of follow up, but disappeared again in 54% of those patients. The prevalence of anaemia varied from 39% to 53% throughout follow up. Iron depletion was found in 38% of anaemic patients; 40% of them did not recover from their anaemia after iron supplementation and were classified as having anaemia of chronic disease. Anaemia of chronic disease thus caused 77% and iron deficiency anaemia 23% of observed anaemia. Recovery from anaemia occurred in 42% of the patients with anaemia of chronic disease and in 72% of iron depleted patients after iron supplementation. Anaemic patients, particularly those with anaemia of chronic disease, had a significantly greater number of the American College of Rheumatism criteria for RA, significantly more erosive joint damage, and significantly increased concentrations of serum rheumatoid factor than patients without anaemia.
CONCLUSION: Anaemia appeared as a frequent and dynamic manifestation. Recovery and recurrence of anaemia was observed throughout follow up, leading to a longstanding and relatively high prevalence of the condition. Iron deficiency was diagnosed frequently and follow up revealed a considerable overlap with anaemia of chronic disease, making this the most important cause of anaemia in RA. Recovery from anaemia occurred more frequently in iron depleted anaemic patients than in those with anaemia of chronic disease. Anaemic patients, particularly those with anaemia of chronic disease, seemed to have a more serious course of their RA compared with non-anaemic patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8712878      PMCID: PMC1010122          DOI: 10.1136/ard.55.3.162

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  25 in total

1.  Iron status of 38-year-old women in Gothenburg, Sweden.

Authors:  E Rybo; C Bengtsson; L Hallberg
Journal:  Scand J Haematol Suppl       Date:  1985

2.  The anaemia of chronic disorders. A bag of unsolved questions.

Authors:  N E Hansen
Journal:  Scand J Haematol       Date:  1983-11

3.  Serum ferritin as indicator of iron responsive anaemia in patients with rheumatoid arthritis.

Authors:  T M Hansen; N E Hansen
Journal:  Ann Rheum Dis       Date:  1986-07       Impact factor: 19.103

4.  Estimates of iron sufficiency in the US population.

Authors:  J D Cook; B S Skikne; S R Lynch; M E Reusser
Journal:  Blood       Date:  1986-09       Impact factor: 22.113

5.  Serum transferrin receptors in rheumatoid arthritis.

Authors:  A Zoli; L Altomonte; L Mirone; M Magaró; B M Ricerca; S Storti; A Candido; M Bizzi
Journal:  Ann Rheum Dis       Date:  1994-10       Impact factor: 19.103

6.  Assessment of iron stores in inflammation by assay of serum ferritin concentrations.

Authors:  D R Blake; R F Waterworth; P A Bacon
Journal:  Br Med J (Clin Res Ed)       Date:  1981-10-31

Review 7.  Clinical evaluation of iron deficiency.

Authors:  J D Cook
Journal:  Semin Hematol       Date:  1982-01       Impact factor: 3.851

8.  Serum erythropoietin in rheumatoid arthritis and other inflammatory arthritides: relationship to anaemia and the effect of anti-inflammatory treatment.

Authors:  G Birgegård; R Hällgren; J Caro
Journal:  Br J Haematol       Date:  1987-04       Impact factor: 6.998

9.  Serum ferritin levels in anemia of rheumatoid arthritis.

Authors:  R J Smith; P Davis; A B Thomson; L D Wadsworth; P Fackre
Journal:  J Rheumatol       Date:  1977       Impact factor: 4.666

Review 10.  The anemia of chronic disease.

Authors:  G R Lee
Journal:  Semin Hematol       Date:  1983-04       Impact factor: 3.851

View more
  16 in total

1.  Intravenous ferric carboxymaltose is effective and safe in patients with inflammatory rheumatic diseases.

Authors:  Ugo Salvadori; Fabio Vittadello; Ahmad Al-Khaffaf; Armin Maier; Paola C Cappelletto; Massimo Daves; Bernd Raffeiner
Journal:  Blood Transfus       Date:  2019-12-13       Impact factor: 3.443

Review 2.  Anaemia in inflammatory rheumatic diseases.

Authors:  Günter Weiss; Georg Schett
Journal:  Nat Rev Rheumatol       Date:  2012-11-13       Impact factor: 20.543

3.  Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trial.

Authors:  H R Peeters; M Jongen-Lavrencic; G Vreugdenhil; A J Swaak
Journal:  Ann Rheum Dis       Date:  1996-10       Impact factor: 19.103

4.  Anemia in rheumatoid arthritis: high prevalence of iron-deficiency anemia in Indian patients.

Authors:  Sumeet Agrawal; Ramnath Misra; Amita Aggarwal
Journal:  Rheumatol Int       Date:  2006-05-04       Impact factor: 2.631

5.  Erythroferrone Expression in Anemic Rheumatoid Arthritis Patients: Is It Disordered Iron Trafficking or Disease Activity?

Authors:  Soha R Youssef; Esraa H Hassan; Caroline S Morad; Adel A Elazab Elged; Rasha A El-Gamal
Journal:  J Inflamm Res       Date:  2021-09-07

6.  [Anemia in patients with rheumatoid arthritis].

Authors:  M Wahle
Journal:  Z Rheumatol       Date:  2012-12       Impact factor: 1.372

7.  Anemia in monkey collagen-induced arthritis is correlated with serum IL-6, but not TNFalpha.

Authors:  Yasushi Uchiyama; Nobuo Koike; Masahiko Mihara
Journal:  Rheumatol Int       Date:  2008-02-29       Impact factor: 2.631

8.  Serum Copper as a Marker of Disease Activity in Rheumatoid Arthritis.

Authors:  Montosh Chakraborty; Happy Chutia; Rita Changkakati
Journal:  J Clin Diagn Res       Date:  2015-12-01

Review 9. 

Authors:  C Kneitz; J Atta; H Burkhardt
Journal:  Z Rheumatol       Date:  2017-10       Impact factor: 1.372

10.  Burden of anemia in patients with osteoarthritis and rheumatoid arthritis in French secondary care.

Authors:  Gergana Zlateva; Ruth Diazaraque; Muriel Viala-Danten; Liviu Niculescu
Journal:  BMC Geriatr       Date:  2010-08-26       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.